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Highlights 
 It is unclear if a recovered pain condition leaves traces of higher sensitivity of pain mechanisms  
 Pain is more frequently referred to the previous area of nociceptive activity 
 The pain area in the previously painful area is enlarged compared with controls 
 The ability to dampen pain via endogenous inhibition seems improved after recovery from pain  
 The findings shed a light on the mechanisms involved in recovery from musculoskeletal pain 
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ABSTRACT  
Facilitated pain mechanisms have been demonstrated in musculoskeletal pain but it is unclear whether 
a recent painful injury leaves the pain system sensitized. Pain characteristics were assessed in 
individuals who recently recovered from ankle pain (recovered pain group; n=25) and sex-matched 
controls (n=25) in response to tonic-pressure pain and saline-induced pain applied at the shin muscle. 
Pain intensity and pain referral patterns were recorded bilaterally after the painful muscle stimulus. 
Pressure pain thresholds (PPTs) were measured at the lower legs and shoulder. Cuff pressure algometry 
on the lower leg was used to assess pain detection threshold (PDT), pressure evoking 6-cm pain score 
on a 10-cm visual analogue scale (PVAS6), pain tolerance (PTT), temporal summation of pain (TSP), 
and conditioned pain modulation (CPM). Compared with controls, saline-induced and pressure-induced 
pain in the shin muscle were more frequently felt as referred pain in the previously painful ankle 
(P<0.05) and the pain area within the previously affected ankle was larger following saline-induced 
pain (P<0.05). In the recovered pain group, CPM responses and the cuff pressure needed to reach 
PVAS6 was higher in the previously painful leg compared with the contralateral leg (P<0.05). No 
group differences were found in PPT, PDT, PTT, and TSP.  
 
Perspectives 
These explorative findings demonstrate that pain mechanisms responsible for pain location may be 
reorganized and continue to be facilitated despite recovery. A large prospective study is needed to 
clarify the time profile and functional relevance of such prolonged facilitation in the pain system for 
e.g. understanding recurring pain conditions. 
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INTRODUCTION 
Musculoskeletal pain affects a vast majority of the population at some stage during the lifespan
4
. After 
an initial painful musculoskeletal event, such as whiplash or an acute back sprain, recurrent episodes of 
pain separated by pain-free periods are common
11,18,31
. Although, the mechanisms for pain recurrence 
are unclear unresolved tissue pathology is not considered a driving factor
24
.    
Several studies have demonstrated that facilitated central pain mechanisms are associated with 
persistent and widespread pain in a number of musculoskeletal patient populations
15
. The central 
processing of on-going nociceptive stimuli continues until it gradually subsides following the healing 
of trauma-related tissue damage. Ongoing nociceptive stimuli can drive neuroplasticity and contribute 
to facilitated central pain mechanisms
27
. In chronic pain conditions maladaptive neuroplasticity may 
manifest as increased pain sensitivity
10,15
, facilitated temporal summation of pain
45
, reduced efficacy of 
descending pain inhibition assessed by conditioning pain modulation (CPM)
44
, and expanded pain 
referral
15
. Furthermore, individuals recovering from acute low back pain may present with impaired 
CPM
33
 and facilitated temporal summation
43
. It is however unclear whether such an enhancement is 
still present in individuals who have recovered from painful injury.  
In healthy subjects, weekly intramuscular injections of hypertonic saline inducing pain with short 
duration can lead to progressively larger areas of referred pain
39
. The repetitive nature of the 
nociceptive insult may underlie the progressive expansions in the referred pain. In general, the 
mechanism for location of referred pain is not fully understood.   Saline-induced pain in the tibialis 
anterior or brachioradialis muscles frequently but not always gives referred pain to the ankle and wrist 
area, respectively
14
. Interestingly, an experimental nociceptive stimulus to the maxillary sinus resulted 
in a pain experience at the site of a recent dental procedure
21
. These experimental findings may indicate 
that individuals with a recent painful injury may be more susceptible to a subsequent painful event 
evoking referred pain to the area originally traumatized.  
This study was designed to assess the referred pain response to experimental pain as well as the 
pain sensitivity, temporal pain summation, and CPM in individuals recently recovered from ankle pain, 
as compared to controls. It was hypothesized that i) pain referral pattern induced from the tibialis 
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anterior muscle towards the ankle region is larger and occurs more frequently in individuals who 
recently recovered from a pain condition in the ankle, and ii) in these individuals residual effects of 
changed central pain mechanisms are reflected as increased pain sensitivity, a facilitated temporal pain 
summation and reduced CPM. The goal of this explorative study was to assess residual effects in 
central pain mechanisms that may contribute to recurrent pain and form basis for a future large-scale 
study.  
 
 
METHODS  
Subjects  
Asymptomatic male and female participants were recruited from a university population and local 
sports clubs and divided into two groups: A group with prior history of soft-tissue injury or idiopathic 
pain from the ankle region, within 3 months from the data collection (recovered pain group) as well as 
a control group consisting of sex and age matched individuals.  
 
Recovered pain group 
Participants were recruited in this group if they had a recent history of on-going ankle pain with or 
without an injury were included, pending a return to normal daily function and without spontaneous or 
on-going pain in the ankle or lower limb (i.e. completely asymptomatic). No effort was made to 
differentiate between pain conditions related to an injury (e.g. an ankle sprain) or pain that was brought 
on spontaneously with or without a previous history of an injury to the area. This was done to allow 
their recent pain condition to be related with a previous injury (>12 weeks) that had recovered but was 
aggravated by e.g. strenuous physical activity which they had experienced within the 12 weeks prior to 
recruitment. The rationale behind this was the high recurrence rates of ankle and foot injuries after the 
first episode
6
 and therefore the small chances of finding adults with only a single, recent lifetime 
episode of pair or injury to the foot or ankle. This was therefore noted at inclusion (see table 1) but not 
used as an exclusion criteria. Participants in the recovered pain group had been pain-free for a 
minimum of 2 weeks prior to participation after recovering from an injury or a pain condition that 
limited normal function within the previous 3 months.  
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Control group 
The volunteers in the control group were likewise pain-free at the time of data collection. Due to the 
fact that injuries to the foot and ankle are frequent, especially in childhood and adolescence
7
, only 
persons with no previous history of substantial ongoing pain or injury to the lower limb/ankle regions 
were included. A substantial ongoing pain or injury was defined as fracture to the foot or ankle or a 
surgical procedure aimed at rectifying a musculoskeletal injury in the area. Subjects with a recent 
(within 12 weeks) history of pain or minor injury to the ankle/foot were not included in the control 
group.  
 
For both groups, a current or recent (within 3 months) significant pain condition to other body 
parts/regions was an exclusion criterion. All participants were naïve to the experimental procedure at 
inclusion in the sense that they had not participated in a similar experimental pain study previously. A 
total of 55 healthy participants (26 females) with a mean age of 24 years (range 18 – 35 years), a mean 
weight of 74 kg (range 49 – 110 kg), and an average height of 176 cm (range 156 – 200 cm) were 
recruited for the study.  
Prior to inclusion, participants were screened by the principal investigator (TSP) who is an 
experienced physiotherapist specialized within musculoskeletal pain. All participants were healthy and 
completely pain-free at inclusion. Participants who were pregnant or reporting any systemic diseases 
were excluded. For both groups, any history of surgery of the lower limbs and use of any form of 
medication at present or on-going was noted at inclusion but not considered a direct exclusion criteria. 
In case any of the study participants did not tolerate the experimental procedures, they were excluded 
from the study and all collected data from them was removed from the final dataset.  
Participants received a written and oral description of the study prior to giving their informed 
consent. The study was conducted in accordance with the Helsinki Declaration and approved by the 
regional Ethics Committee (N-20120004).  
 
Experimental protocol  
A flow-chart of the study protocol is shown in figure 1. The study was a single blinded (assessor was 
blind to group allocation), cross-sectional group comparison conducted in one 90-minute session where 
participants rested in a reclined sitting position. First, the pain sensitivity was assessed by pressure pain 
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thresholds (PPT) at three bilateral body sites. Secondly, the distribution of experimentally induced pain 
referral was assessed by two different methods applied to the tibialis anterior muscle (initially by tonic 
pressure pain stimulation, then by hypertonic saline injection, and subsequently by tonic pressure pain 
stimulation). In a balanced randomized order, experimental pain referral was induced first in the un-
injured leg or the previously painful leg (test leg) for the recovered pain group. The same 
randomization approach was used for the dominant leg (defined as test leg) and non-dominant leg in 
the control group. PPTs were reassessed during saline-induced pain and following a 5 min pain-free 
period. Subsequently, cuff pressure pain sensitivity and temporal summation of pain was assessed 
using cuff algometry on both legs starting with the test leg. Finally, cuff algometry was used to assess 
the effectiveness of endogenous pain inhibition by using a conditioning pain modulation paradigm with 
the conditioning stimulation on the test leg and the cuff test stimulus on the contralateral leg.  The 
hypotheses of the study were not introduced to any of the subjects prior to their participation.   
 
Pressure pain sensitivity 
Pressure-pain thresholds (PPT) were assessed bilaterally and marked for multiple assessments: (1) The 
deltoideus muscle, over the bulky medial part of the muscle, midway between acromion and the deltoid 
tuberosity. (2) The tibialis anterior (TA) muscle, two fingerbreadths medial and two fingerbreadths 
inferior to the fibular head. (3) The talocrural joint, at the mid-point between the medial and lateral 
malleolus immediately lateral to the tendon of the tibialis anterior muscle (Fig. 2). A handheld pressure 
algometer (Algometer
®
, Somedic, Sweden) with a 1 cm
2
 probe (covered by a disposable latex sheath) 
was used to apply increasing pressure with a ramp of 30 kPa/s. The PPT was defined as the moment the 
pressure became painful as indicated by the participants pressing of a button to end the test. At 
baseline, the three individual PPTs were acquired on each site with a minimum 30 s between 
assessments. The subsequent assessments were based on two PPT assessments for each time point. The 
average of the PPTs acquired at each site for each time point was used for statistical analysis and for 
calculating the stimulation intensity used for tonic pressure-induced pain. PPTs were normalized with 
the baseline values (‘during pain’ and ‘post pain’ divided by ‘baseline’ values). 
 
Tonic pressure-induced pain referral 
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The tonic pressure pain stimulation intensity was defined as 120% of the baseline PPT assessments and 
applied to the TA muscle site for 60 s using a computer-controlled pressure algometer (Aalborg 
University). The participant could ‘stop’ the supra-pain threshold pressure pain stimulation by pressing 
a handheld button. During the stimulation, the leg was stabilized using a vacuum pillow (AB GERMA, 
Kristianstad, Sweden). 
 
Saline-induced pain referral 
Sterile hypertonic saline (1 ml, 5.8%) was injected over approximately 10 s into the belly of the TA 
muscle (same site as used for pressure algometry). Prior to injection, the skin was cleaned using 
standardized disinfection protocols. Injections were performed using a 2 ml plastic syringe with a 
disposable needle (27G). Recording of the pain intensity was initiated immediately after the injection 
using a 10-cm electronic visual analogue scale (VAS) with an external handheld slider to adjust the 
scale. The VAS was anchored with ‘no pain’ and ‘maximum pain’, 0 cm and 10 cm, respectively. The 
VAS signal was recorded until the perception of pain subsided (sampling frequency of 25 Hz). The 
peak pain (VAS-peak) and area under VAS-time curve (VAS-area) were extracted and used for data 
analysis. The pain duration was defined as the time difference between the first and the last time the 
VAS score was greater than zero. In case VAS scores did not change from baseline, the pain duration 
was set to zero. 
 
Assessment of saline and tonic pressure-induced pain area  
After the saline or tonic pressure-induced pain subsided, participants were asked to draw the area of 
pain and extent on an electronic three-dimensional body chart of the lower legs (anterior view) on a 
10.1” tablet (Samsung Galaxy Note 10.1, Navigate Pain application, Aglance Solutions, Aalborg, 
Denmark). Participants were asked to draw with a tablet pen (1.5 mm pen tip). Participants were asked 
to draw the area(s) of their pain-induced symptoms as accurately as possible and to the best of their 
ability. According to Graven-Nielsen
14
, the majority of healthy individuals express pain referral to a 
varying extent when similar pain models have been used. This was therefore expected to occur in this 
study. To ensure proper blinding and that the participants did not know that this was expected, they 
were specifically asked to mark all areas where they experienced pain-induced symptoms, regardless of 
whether these were experienced proximal or distal to the stimulation site on both sides of the body. The 
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subject was further instructed to paint the whole area instead of indicating it by e.g. drawing a circle 
around it or marking the area with a cross. Using this technique has been shown to be reliable when 
compared with a two dimensional paper drawing
3
. 
For quantification of pain distribution, the body chart was divided into 3 pre-defined regions in 
the frontal plane (Fig. 2): The stimulation area (region 1) in and around the upper part of lower leg up 
to the knee, the lower part of the leg, down to a line connecting the malleoli (region 2, talocrural 
region), and the ankle and foot, distal to a line connecting the malleoli above (region 3, foot region). 
The foot region represented the previous injury area in the group with recovered pain. For each region, 
the pain area (expressed as number of pixels, extracted from the drawing on the tablet and reported as 
arbitrary units (a.u.)) was determined for individual drawings. Furthermore, the frequency of pain 
occurrence was expressed in each region.  
 
Cuff algometry 
A cuff algometer (NociTech, Aalborg, Denmark and Aalborg University, Aalborg, Denmark) was used 
to assess the cuff-pressure pain sensitivity, temporal summation of pain, and conditioned pain 
modulation
17,41,46
. A double-chamber cuff (VBM, Sulz, Germany) was placed on the lower leg, with the 
upper rim of the cuff being in level with the tibialis anterior (covering the tibialis anterior PPT site). 
First, the cuff-pressure pain sensitivity was determined on the test leg and subsequently on the 
contralateral leg. For the cuff-pressure pain sensitivity assessments, both chambers of the cuff were 
inflated gradually (1 kPa/s) until the pressure became intolerable and the participant pressed a stop 
button upon which the cuff was immediately deflated. The participant used an electronic VAS scale to 
continuously rate the intensity of pressure pain where 0 cm defined ‘no pain’ and 10 cm anchored 
‘maximal pain’. Cuff-pressure pain sensitivity was investigated in three different ways: 1) The pain 
detection threshold (PDT) was defined as the point where the VAS score exceeded 1 cm the first time. 
2) The pain tolerance threshold (PTT) was the pressure value where the subject stopped cuff inflation 
because of intolerable pain. Finally, 3) the pressure intensity at a VAS score of 6 cm (PVAS6) was 
extracted to investigate the response to a supra-pain threshold test-stimuli in accordance with previous 
procedures
16
. The PDT, PVAS6, and PTT were recorded twice for each leg and the average value used 
for further analysis. In case the PTT was not reached before reaching the safety limit (100kPa) of the 
cuff algometer, then the pain tolerance threshold was defined as 100 kPa.   
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Temporal summation of pain was assessed by a repetition of ten 1-s long cuff pressure stimuli 
with a 1-s break in between. To secure that all subjects received the same relative stimuli, the 
stimulation intensity was set to each individual’s PTT value. When not stimulating (in the 1-s break 
between stimuli), a pressure of 1 kPa was kept to maintain cuff position. Reaching the designated 
stimulation intensity took less than 0.5 second. The subject was asked to rate the pain intensity 
continuously during the repeated stimulations using the electronic VAS scale although not returning 
towards zero between stimulations. For data analysis, the mean VAS score in the break after each 
stimulus was extracted. VAS data was normalized to the first stimulus and then the ratio of mean VAS 
score of the first four (VAS-I) and the last three (VAS-III) stimuli was calculated as the temporal 
summation index (TSP-ratio) as this method has previously shown good reliability in patients and 
healthy populations
17,47
. An increased TSP-ratio indicates a more efficient temporal pain summation. 
The repeated stimulation protocol was recorded twice for each leg and the average TSP-ratio was used 
for further analysis.  
For assessment of the conditioned pain modulation, the cuff-conditioning stimulus induced by the 
double cuff positioned on the leg contralateral to the test leg and inflated to 80% of PTT for that leg. 
Tonic pressure in the cuff was maintained while two rounds of PPT recordings were done using 
handheld algometry at each site on the test side. The cuff was deflated following the PPT recording. 
The ratio between baseline PPT values and PPT values assessed during the conditioning stimulus 
(where an increased CPM-ratio indicate better conditioning pain modulation) was extracted and used 
for analysis.  
For assessment of the conditioned pain modulation, the cuff-conditioning stimulus induced by the 
double cuff positioned on the leg contralateral to the test leg and inflated to 80% of PTT for that leg. 
Tonic pressure in the cuff was maintained while two rounds of PPT recordings were done using 
handheld algometry at each site on the test side. The cuff was deflated following the PPT recording. 
The ratio between baseline PPT values and PPT values assessed during the conditioning stimulus was 
extracted and used for analysis.   
 
Statistics 
Parametric data are presented as mean and standard errors of the mean (SEM) and non-parametric data 
as median and interquartile range [IQR, 0.25 – 0.75]. For repeated measures, an adjustment for the 
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order effect for the injections (first vs second leg) as well as sex were performed for PPT, cuff-
algometry parameters, VAS parameters, and pain referral measures.  
VAS pain parameters (VAS-area, VAS-peak, and VAS duration) passed the Lilliefors test for 
normality and were therefore analyzed with a two-way ANOVA with group (recovered pain, controls) 
as between group factor and leg (test leg, contralateral leg) as repeated measure. Baseline raw PPT 
values were analyzed with a two-way ANOVA with group and leg factors. For each of the three 
assessment sites, a three-way ANOVA of the PPTs were performed with the group and leg factors as 
well as time (during, post) as repeated measures. In case of main or interaction effects, post-hoc 
comparisons were performed with the Newman-Keuls test adjusting for multiple comparisons. The 
TSP-ratio was analyzed with a Kruskal-Wallis ANOVA with comparisons both between groups and 
between legs. In case of main or interaction effects, post-hoc comparisons were performed with the 
Mann-Whitney U test with a Bonferroni correction to account for multiple comparisons. The CPM-
ratio was compared between the two groups using a mixed model ANOVA with a Bonferroni 
correction to adjust for multiple comparisons. 
The pain areas were not normal distributed and were thus analyzed with a one-way Kruskal-
Wallis ANOVA across groups (all 4 legs). For post-hoc analyses, a Mann-Whitney U test was applied 
to detect differences between the test legs, control legs within and between groups with a Bonferroni 
correction applied to correct for multiple comparisons. The Bonferroni correction was applied with a 
factor 4 (2 groups, 2 sides). The frequency of pain reported in each region was analyzed by the Fisher’s 
exact test. A correlation analysis was run to investigate the relationship between pain distribution and 
the VAS parameters. Furthermore, a correlation analysis was run to investigate the potential 
relationship between the duration of the last painful episode and the size of pain area in each region of 
the lower limb. Based on data distribution, either the Pearson’s product-moment correlation or 
Spearman’s rank correlation coefficient was calculated. For all analyses, a significance level of 0.05 
was accepted. 
 
 
RESULTS 
Five subjects were excluded from the study; 4 persons did not feel well during saline-induced pain (two 
from control group) and one subject was excluded from the recovered pain group who had a previous 
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history of a serious disease which was not revealed at inclusion. Therefore, the data from 50 individuals 
(24 women), 25 in each group were included in the statistical analysis. For demographic description, 
see Table 1. All subjects were pain-free on the day of testing, both at rest and during the screening of 
active movements conducted by the primary investigator (TSP). A median duration from the painful 
ankle trauma of 28 days in the recovered pain group. A majority of the participants in the recovered 
pain group had experienced repeated episodes of pain from the ankle or foot prior to their latest one 
(recurring pain 19 out of 25) with full recovery between episodes. They had however, all been pain free 
in the two weeks prior to the experimental session.   
Adjusting for sex did not change the outcomes of the below analysis and therefore the results 
represent both sexes. Likewise, adjusting for the sequence of testing (order effect) did not have an 
effect on the outcomes from the analysis.  
 Pressure pain sensitivity 
The ANOVAs of baseline PPT at the shoulder, tibialis anterior muscle, and ankle sites, respectively, 
were not different between sides (test-leg, control leg) and groups (ANOVA: F(2, 48) = 0.46, P < 0.5) 
(Table 2). Likewise, the ANOVA of PPTs did not show effects of group during and post saline-induced 
pain when comparing changes from baseline in PPTs following saline injection although a tendency 
towards reduced PPT’s was found in the previously injured leg (ANOVA: F(2, 84) = 1.22, P < 0.3) 
(Table 3).  
 
Saline-induced pain intensity 
The ANOVA demonstrated no significant main effects or interactions between group or legs when 
comparing the VAS-area (ANOVA: F(1, 48) = 2.6, P < 0.1) and VAS-peak (ANOVA: F(1, 48) = 0.8, P 
< 0.4), respectively, in the recovered pain group (test-leg: 1503.3 ± 157.5 cm·s; 5.7 ± 0.4 cm; 
contralateral leg: 1442.1 ± 142.6 cm·s; 5.7 ± 0.4 cm) and control group leg (test-leg: 1447.7 ± 159.4 
cm·s; 5.8 ± 0.5 cm; contralateral leg: 1663.1 ± 159.7 cm·s; 6.1 ± 0.5 cm). Furthermore, the ANOVA 
showed no difference (ANOVA: F(1, 48) = 3.3, P < 0.07) when comparing the duration of pain in the 
control group (test leg: 980.9 ± 56.7 s; contralateral leg: 1004.8 ± 53.9 s) and the recovered pain group 
test (test leg: 1091.8 ± 64.8 s; contralateral leg; 1003.3 ± 43.9 s). 
 
Saline-induced pain distribution 
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When comparing the groups in terms of side differences, extensive pain referral patterns were noted 
bilaterally in both groups (Fig. 3), with no group differences in total size between the test legs (control 
group: 19186 [9399 - 26249], recovered pain group: 22729 [14197 - 25945]) or the control leg (control 
group: 17655 [10164 - 28155], recovered pain group: 14696 [11016 - 24209], χ
2
(3)= 1.534 ; P > 0.67). 
Similarly, the total number of pain-affected regions between legs did not differ. When investigating the 
pain area in each region, the Kruskal-Wallis ANOVA demonstrated a significant effect for the foot 
region (χ
2
(3) = 9.235, P < 0.002), with larger pain areas in the test leg in the recovered pain group 
compared with the test leg in the control group (Chi-square P < 0.01; Fig. 3; Table 4). Furthermore, 
hypertonic saline evoked referred pain more frequently in the foot region in the test leg of the 
recovered pain group when compared with the control group (Fisher’s exact test: P < 0.005, Table 5).  
No correlation was found between the size of the pain referral pattern and pain intensity 
following hypertonic saline injection (Spearman’s rho: P > 0.05). Likewise, no correlation was found 
between the duration of pain (in days) and the size of referred pain in any of the regions in the lower 
limb (Spearman’s rho: P > 0.05) 
 
Tonic pressure-induced pain distribution 
No group or leg differences were found when comparing the total pain distribution following tonic 
pressure pain stimulation at baseline or post saline-induced pain (Table 6). However, the Fisher’s exact 
test demonstrated that tonic pressure stimulation at baseline evoked referred pain in the talocrural 
region of the test leg more frequently in the recovered pain group compared with the control group 
(Fisher’s exact test: P < 0.01, Table 5).   
 
Cuff pain detection threshold and pain tolerance threshold 
For the pain tolerance threshold, 5 subjects in the recovered pain group and three subjects in the control 
group reached the machine’s cut-off (100 kPa). This value was therefore registered as their pain 
tolerance threshold. No difference was found when comparing the PDT or PTT between the legs and 
groups (Table 5). However, the ANOVA of the PVAS6 demonstrated an interaction between group and 
leg (ANOVA: F(1, 48) = 4.09, P < 0.049) with a post-hoc analysis revealing higher PVAS6 in the test 
le compared with the control leg for the recovered pain group (Table 5; NK: P < 0.03).  
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Temporal pain summation and conditioning pain modulation 
The tests of temporal summation, revealed no differences in the ratio between VAS-I and VAS-III 
between the recovered pain group (test leg: median 1.8 [1.2 – 2.8], control leg: 1.4 [1.1 – 1.9]) and the 
control group (test leg: median 1.2 [1.0 – 1.7], control leg: 1.3 [1.0 – 2.0], Kruskal-Wallis: χ 
2
(3) = 
4.524, P < 0.2). For the CPM effect, the ANOVA  demonstrated a significant interaction between 
´group´ and ´sites´ (ANOVA: F(2, 96) = 4.6, P < 0.01) where the CPM effect at the ankle was greater 
in the recovered pain group (26.9 ± 4.9%) compared with the control group (8.5 ± 5.5%, P < 0.016). 
No difference in CPM response was found when comparing deltoid (recovered pain group: 15.5 ± 
4.3%, control group: 21.2% ± 5.4%) or the injection site (recovered pain group: 38.8 ± 7.8%, control 
group: 20.9 ± 5.8%).  
 
 
DISCUSSION  
This explorative study is the first to assess pain characteristics in individuals recently recovered from 
ankle pain. Although baseline characteristics were comparable, conditioned pain modulation was seen 
to be improved around the ankle in the recovered pain group. Moreover, the extent and distribution of 
the referred pain pattern in response to experimental pain manifested as an enlarged pain referral area, 
specifically in the ankle region in the recovered pain group. Together, these findings suggest a selective 
rather than generalized spread in nociceptive processing when recovered from ankle pain. 
  
Increased pain referral and the sensitized pain system 
Referred pain is defined as pain felt remote to the site of origin/stimulation
1
. It is well known in clinical 
practice
2,5,9,26,35
 and reproducible in experimental settings
34,37
.  
The hypertonic saline model caused a more extensive pain referral than tonic pressure, similar to 
previous findings
8
 and may relate to differences in pain intensity. Painful pressure results in a time-
related increase in pain area
13
 which may indicate that the participants in this study were under-
stimulated by only receiving a 60s stimulation  with PPT+20%. However, pain intensity during tonic 
pressure was not registered in this study, making comparisons to previous findings speculative.  
The injection site in this study receives innervation from spinal segments L4-S3
42
 and the 
talocrural joint (which is commonly  affected in ankle injuries) receives innervation from mid and 
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lower levels of the lumbosacral plexus
42
. Therefore, a neuroanatomical overlap exists between the 
spinal segments receiving afferent information from both sites. This overlap may explain why healthy 
individuals in the current and previous studies
12,13
, show distal expansions of referred pain following 
hypertonic saline.  
Despite the group differences in pain referral, it noteworthy that the median size of pain area over the 
ankle and foot was relatively small in the control group compared with the recovered pain group (Table 
6). Considering the random order of saline injections into the test leg and control leg in both groups, 
this may be difficult to explain. The differences may however be driven by the smaller number of 
controls reporting pain in the area (N=16) compared with the recovered pain group (N=24, Table 4) in 
addition to the large variability in referred pain within the groups (table 6). 
 
 
Injury-induced changes in nociceptive processing  
No significant differences were found for measures of pressure pain sensitivity and temporal pain 
summation. Considering that widespread pain is a common feature in clinical populations
22,44
, the 
current findings suggest that the two groups are responding in a similar, normal manner.  
Interestingly, higher cuff-pressure was needed to evoke pain equal to 6 cm on VAS in the 
previously painful leg, compared to the contralateral leg in the recovered pain group. Furthermore, a 
higher CPM response was seen at the talocrural joint in the recovered pain group compared with 
controls. This may reflect an ongoing, selective regional gain of pain inhibition, and may potentially be 
considered a healthy, adaptive response. The authors are unaware of studies demonstrating such a 
selective shift in pain inhibition following recovery from a painful injury. If this occurs, the current 
findings may reflect a protective mechanism that might be part of the recovery process. A prospective 
cohort study is needed to investigate if this occurs when recovering from an injury. The seemingly 
increased efficiency of descending inhibitory mechanisms contrasts the facilitated referred pain to the 
previously painful ankle seen here. However, recent findings indicate that a painful conditioning 
stimulus does not affect the size of pain referral evoked by experimental pain
28
, suggesting that 
mechanisms for referred pain and descending pain control appear to be active, independent of each 
other.  
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This present study observed that following full recovery from a recent period of ankle pain, 
resulted in an increase in area and frequency of experimentally-induced referred pain over the ankle 
region. Although the actual area of expansion is relatively small, this may relate to the ankle region 
being small compared to the lower leg as a whole. These findings are in line with previous observations 
where a painful experimental stimulus resulted in a pain projection towards the a site that was 
previously the locus of a strong nociceptive stimulus
21
.  
Approximately 80% of healthy subjects develop pain in the ankle area following hypertonic 
saline injections into the tibialis anterior muscle
14
 which is consistent  with the frequency of referred 
pain in the control group in the present study. Interestingly, this ratio is shifted in the recovered pain 
group where almost all subjects reported pain in the ankle region (23/25) and the foot region (24/25).  
Existing evidence suggests that this may occur via expanding receptive fields at the spinal level
20
 and 
sensitization of central rather than peripheral mechanisms
32,48
. Moreover, recent experimental 
findings
30,36
 show that processing of pain intensity and spatial distribution of symptoms does not 
involve the same brain areas. In his study, subjects performed discriminative tasks consisting of rating 
pain intensity followed by recording pain location. Supraspinal activity during spatial focus may in this 
way shift information processing away from the intensity of the nociceptive stimulus
30
. The intensity 
and duration of the hypertonic saline-induced pain profile were similar to what has been shown 
previously
13
 with no difference found between the two groups. Further, no relationship was found 
between spatial distribution of pain and VAS parameters in contrast to previous findings
14,38
. Although 
speculative, this may explain the group differences in pain distribution despite similarities in VAS 
profiles seen in the current study. It is known that long-term changes in synaptic strengthening and 
central nervous system re-organization are related to the intensity and duration of the initial painful 
stimulus
23
 but even low intensity, on-going nociceptive stimuli can maintain sensitization of central 
pain mechanisms
49
. This may imply that the relatively long duration of the last painful clinical episode 
(Table 1) may have contributed to functional changes in the central nervous system resulting in the 
shifted pain referral pattern.  
 
 
Limitations and perspectives 
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The control group consisted of individuals with no current or previous history of ongoing pain. 
However, even though it is questionable whether individuals over 18 years may have gone through life 
without sustaining an injury, this would have provided a more conservative estimate of the group 
differences in the present study.  
Two main limitations in this study are the divisions used to allocate the ankle regions and 
subsequent areas of pain and the time of the initial ankle injury to study onset were not uniform (Table 
1). The divisions used in this study reflect anatomical landmarks and were based on a-priori knowledge 
of pain referral patterns
12,13
. The present findings were a result of an exploratory investigation and 
require a prospective follow-up to determine whether referred pain can be increased by residual 
neuroplasticity expressed as e.g. enhanced functional connectivity of synaptic connections in the 
central pain system
14,25,40
. The transition from injury to recovery as assessed by on-going pain or 
functional measures could be standardized by systematically assessing individuals at regular intervals 
following injury prospectively. This might clarify whether extended pain referral patterns remain or 
dissipate over. Another consideration is that a significant proportion of the asymptomatic individuals 
experienced repeated episodes of ankle pain and thus may represent a subgroup e.g. recurrent versus 
initial ankle injuries. This study was however, underpowered to deal with such an investigation. Given 
the explorative nature of this study, these findings can be fruit for further investigations.  
In general, the statistical findings favor the research hypothesis. However, the large variation in 
pain area suggests that injuries and/or referral patterns are not uniform. Therefore, it must be 
acknowledged that the diagnostic utility of these findings is limited. Furthermore, some of the findings 
seem not only driven by extended pain referral in the recovered pain group, but also by a smaller 
proportion of controls reporting pain at the most distal sites (see e.g. table 4). Lastly, it is important to 
consider that multiple comparisons within and between groups were made in this study. Even though 
these were controlled for, it is plausible that some of the findings are random.  
Although the size of pain area is not related with catastrophizing thoughts in patients with chronic 
musculoskeletal pain
29
, it seems to be different in more acute pain conditions
19
. An assessment of 
catastrophizing thoughts is therefore warranted in future studies. Despite limitations, the findings raise 
queries as to whether individuals with a recent history of pain are subject to a continuous and 
peripheral nociceptive input that is suppressed by an increased gain in pain inhibition. Residual effects 
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in the spinal or supraspinal system would account for the dynamic nature of recurrent or episodic pain 
and indicate the involvement of central pain mechanisms.    
 
Conclusion 
This exploratory study shows an expansion in referred pain patterns to a previous pain area in 
otherwise asymptomatic individuals. In the recovered pain participants, an increased gain in the 
descending inhibitory systems was also found. These preliminary findings warrant a larger prospective 
study to clarify the time profile and functional relevance for e.g. recurrent pain episodes. 
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Table 1. Demographic data (N=50, 25 in each group) is presented as mean (range), sex distribution as 
percentage of females in each group. Time in days since subjects last had pain from the ankle are 
presented as median [IQR]. Number of days away from full physical activity following injury are 
presented as median [IQR]. The number of subjects with a recurring pain problem related to the ankle 
or foot is presented. 
 
Sex 
(women) 
Age 
(years) 
Height 
(cm) 
Weight 
(kg) 
Post-pain 
time (days) 
Duration of pain-
induced 
disability (days)  
Recurring pain 
episodes  
(% subjects)  
Control 
group 
44% (N=11) 25 (19 - 35) 176 (156 - 194) 74 (51 - 110) N/A N/A N/A 
Recovered 
pain group 
52% (N=13) 24 (18 - 30) 178 (157 - 200) 75 (49 - 102) 28 [14 - 56] 19 [7 - 42] 76% (N=19) 
 
Table 2. Mean (±SEM, N=25) baseline pressure pain thresholds (PPT) at the three assessment sites. No 
significant group differences were found (P > 0.05). Note: The test leg in recovered pain group reflects 
ankle with prior injury or pain. 
Baseline  
Pressure pain thresholds (kPa) Tibialis anterior Medial deltoid Talocrural joint 
C
o
n
tr
o
l 
 
 g
ro
u
p
 
Test leg  431.6 ± 36.6 342.0 ± 27.5 397.6 ± 21.4 
Control leg  430.3 ± 35.0 350.0 ± 31.1 412.9 ± 23.6 
R
ec
o
v
er
ed
 
p
a
in
 
G
ro
u
p
 
Test leg 390.6 ± 31.9 329.1 ± 30.1 401.1 ± 27.9 
Control leg 402.6 ± 30.1 335.7 ± 31.0 408.5 ± 24.7 
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Table 3. Mean (±SEM, N=25) change in pressure pain thresholds (% of baseline) at the three 
assessment sites during saline-induced pain and post saline-induced pain on the test leg and the 
contralateral leg, respectively. Note that the percentage values depict changes that occurred when 
injection was given on the same side.  No significant group differences were found (P > 0.05). Note: 
The test leg in the recovered pain group reflects ankle with prior injury or pain. 
During saline-induced pain  
Pressure pain thresholds (kPa) 
(% of baseline) 
Tibialis anterior Medial deltoid Talocrural joint 
C
o
n
tr
o
l 
 
 g
ro
u
p
 Test leg  97.2 ± 7.9 117.9 ± 4.6 105.1 ± 5.3 
Contralateral 
leg  
86.4 ± 8.0 122.7 ± 6.0 104.7 ± 6.7 
R
ec
o
v
er
ed
 
p
a
in
 
g
ro
u
p
 Test leg 83.7 ± 6.2 112.8 ± 4.8 103.7 ± 4.7 
Contralateral 
leg 
83.1 ± 4.9 115.7 ± 5.3 95.9 ± 5.7 
Post saline-induced pain  
C
o
n
tr
o
l 
 
g
ro
u
p
 Test leg  99.9 ± 6.7 100.9 ± 4.7 109.6 ± 4.6 
Contralateral 
leg  
93.8 ± 7.7 104.8 ± 4.0 109.7 ± 3.9 
R
ec
o
v
er
ed
 
p
a
in
 
g
ro
u
p
  Test leg 98.5 ± 7.1 94.7 ± 3.9 107.9 ± 4.2 
Contralateral 
leg 
89.7 ± 5.6 98.6 ± 5.4 102.5 ± 3.8 
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Table 4 Frequency of affected areas after a painful stimulus (Injection area (area 1) = around the 
injection site, Distal lower leg (area 2) = lowest 1/3 of leg and Ankle and foot (area 3) = foot and 
ankle). Data are presented as sum of affected areas in the test leg and contralateral leg for each group 
(N=25). Significant difference compared with the same side leg in the control group (Fisher’s exact: *, 
P < 0.05)  
  
Regions on the lower limb 
 
Injection 
area 
Distal 
lower 
leg  
Ankle 
and 
foot 
T
o
n
ic
 p
re
ss
u
re
  
b
a
se
li
n
e 
(p
re
-s
a
li
n
e)
 
C
o
n
tr
o
l 
 g
ro
u
p
  
Test leg 23 0 2 
Contralateral 
leg 
23 3 3 
 
R
ec
o
v
er
ed
 
p
ai
n
 g
ro
u
p
 
  
Test leg  24 6* 5 
Contralateral 
leg 
24 5 7 
H
y
p
er
to
n
ic
  
 
sa
li
n
e 
C
o
n
tr
o
l 
g
ro
u
p
 
Test leg 23 20 16 
Contralateral 
leg 
23 21 20 
R
ec
o
v
er
ed
 
p
ai
n
 g
ro
u
p
 Test leg  24 23 24* 
Contralateral 
leg 
24 22 22 
T
o
n
ic
 p
re
ss
u
re
  
p
o
st
-s
a
li
n
e 
C
o
n
tr
o
l 
g
ro
u
p
 
Test leg  23 7 7 
Contralateral 
leg 
22 6 6 
R
ec
o
v
er
e
d
 
p
ai
n
 
g
ro
u
p
  
 
Test leg  24 6 9 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
25 
 
 
 
 
 
Table 5 Mean (±SEM) cuff pressure needed to reach the pain detection threshold (PDT), to reach VAS 
6 cm (PVAS6), and pain tolerance threshold (PTT). Data are presented for the test leg and the 
contralateral leg. No significant group or leg differences were found for PDT and PTT (ANOVA: P > 
0.05), but a significant difference in PVAS6 was found between the test leg and contralateral leg in the 
recovered pain group (ANOVA: *, P < 0.05).  
Cuff algometry 
  Control group Recovered pain group 
P
D
T
 
(k
P
a)
 Test leg  25.7 ± 2.4 27.7 ± 1.9 
Contralateral leg 27.1 ± 2.5 26.4 ± 1.9 
P
V
A
S
6
 
(k
P
a)
 Test leg  44.6 ± 3.3 49.5 ± 3.4* 
Contralateral leg 44.6 ± 3.0 43.8 ± 2.9 
P
T
T
 
(k
P
a)
 Test leg  66.1 ± 4.2 70.6 ± 4.6 
Contralateral leg 64.0 ± 3.8 64.5 ± 4.8 
 
 
 
 
 
 
 
 
Contralateral 
leg 
22 7 11 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
26 
 
Table 6 Median [IQR] Size of pain areas indicated in arbitrary units following suprathreshold 
stimulation at baseline (left column), hypertonic saline (middle column) and following suprathreshold 
stimulation post-pain (right column). Significant difference compared with the same side leg in the 
control group (Kruskal-Wallis: *, P < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Pressure 
(pre-saline) 
Hypertonic 
saline 
Pressure 
(post-saline) 
R
eg
io
n
 1
 (
st
im
u
la
ti
o
n
 
a
re
a
) 
C
o
n
tr
o
l 
 g
ro
u
p
  Test leg 
2168  
[789 - 2686] 
2195  
[251 - 5608] 
2047  
[907 - 4612] 
Contralateral 
leg 
1509  
[225 - 4075] 
3087  
[1425 - 4127] 
2281  
[1515 - 4468] 
R
ec
o
v
er
ed
 
p
ai
n
 g
ro
u
p
 
  
Test leg  1495  
[375 - 3348] 
2387 
 [1150 - 4028] 
2632  
[1873 - 4433] 
Contralateral 
leg 
1446 
 [909 - 2943] 
3014  
[1412 - 4269] 
2581  
[1297 - 3531] 
R
eg
io
n
 2
 (
lo
w
er
 l
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Figure 1. The chronological order of the testing sequence. Measurements of pressure pain sensitivity 
and pain referral (mechanical and saline-induced) were performed in a randomized (leg) balanced 
order. When both legs had been tested, the same sequence was used to assess PDT and PTT using cuff 
algometry. The PTT value was used to determine the stimulation intensity for temporal summation of 
pain and the painful conditioning stimulus used for assessing conditioning pain modulation. The 
experimental session lasted 90 minutes in both groups.  
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Figure 2. Location of assessment sites (indicated with arrows) for pressure algometry (left), and 
outlines of body regions (1, 2 and 3) used for quantification of pain distribution following experimental 
pain (right). All assessments were performed bilaterally although illustrated unilaterally. 
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Figure 3. The area and location of pain referral following suprathreshold stimulation at baseline 
(above) and hypertonic saline injection (below) in the control group, and the recovered pain group. 
Drawings are presented as overlays of all the original individual pain drawings for group on the test leg 
(previously injured leg in the recovered pain group and dominating leg in controls) and the 
contralateral leg (control leg). For the tonic pressure showed dominant areas of pain reports at the site 
of the simulation and for the recovered pain group the pain reports also occurred more distally. In 
contrast, hypertonic saline showed in general showed a greater area of referred pain with the recoverd 
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pain group reporting pain more often over the ankle area. The color-coding (shading) shows the 
percentage of individuals within each group (N=25) reporting pain below the knee and ankle regions. 
Note the image is best viewed in color or greyscale. 
 
